Moreover, there is no histological basis providing the correct and accurate distinction between different PSP phenotypes, excluding assessment of the distribution of tau aggregates (Dickson et al., 2010; Agarwal and Gilbert, 2020). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.